Insmed reported $18.42M in Trade Debtors for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Acelrx Pharmaceuticals ACRX:US $ 104K 554K
Alexion Pharmaceuticals ALXN:US $ 1473M 63.7M
Alimera Sciences ALIM:US $ 15.09M 0.62M
Biomarin Pharmaceutical BMRN:US $ 424.42M 28.32M
Cytokinetics CYTK:US $ 2.7M 1.81M
Dynavax Technologies DVAX:US $ 105.9M 21.91M
Flexion Therapeutics FLXN:US $ 35.23M 4.56M
Gilead Sciences GILD:US $ 4149M 224M
Heron Therapeutics HRTX:US $ 42.62M 4.09M
Insmed INSM:US $ 18.42M 789K
Mirati Therapeutics MRTX:US $ 67.12M 65.28M
Novartis NVS:US $ 8654M 173M
Regeneron Pharmaceuticals REGN:US $ 6998.6M 2825.6M
Sarepta Therapeutics SRPT:US $ 148.26M 11.9M
Seattle Genetics SGEN:US $ 379.74M 43.91M
Ultragenyx Pharmaceutical RARE:US $ 24.72M 0.31M
Vertex Pharmaceuticals VRTX:US $ 929.14M 48.41M